Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

Background<br/> Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine...

詳細記述

書誌詳細
主要な著者: Henriques, G, Phommasone, K, Tripura, R, Peto, T, Raut, S, Snethlage, C, Sambo, I, Sanann, N, Nguon, C, Adhikari, B, Pongvongsa, T, Imwong, M, von Seidlein, L, Day, N, White, N, Dondorp, A, Newton, P, Ley, B, Mayxay, M
フォーマット: Journal article
出版事項: BioMed Central 2018

類似資料